Michael Pepoy
Impact in
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Paraoxonase enzyme and polymorphisms 3
-
- Heart Failure Treatment and Management 1
- Acute Myocardial Infarction Research 1
- Co-authors
- Frederick Van Lente (4 shared papers)Stanley L. Hazen (2 shared papers)Ronnier J. Aviles (2 shared papers)Marlene Goormastic (2 shared papers)Eric J. Topol (2 shared papers)Steven E. Nissen (2 shared papers)Marie‐Luise Brennan (2 shared papers)Marc S. Penn (2 shared papers)
- Journals
- Journal of the American Heart Association (2 papers)Obstetrical & Gynecological Survey (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)Clinical Chemistry (1 paper)
- Partner nations
- United StatesPakistan
In The Last Decade
Michael Pepoy
9 papers receiving 1.1k citations
Michael Pepoy's Hit Papers
Peers
Comparison fields: 5 of 89
- Clinical Biochemistry 144
- Immunology 396
- Cardiology and Cardiovascular Medicine 259
- Biochemistry 40
- Physiology 150
Countries citing papers authored by Michael Pepoy
This map shows the geographic impact of Michael Pepoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pepoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pepoy more than expected).
Fields of papers citing papers by Michael Pepoy
This network shows the impact of papers produced by Michael Pepoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pepoy. The network helps show where Michael Pepoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Pepoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Value of Myeloperoxidase in Patients with Chest Pain Hit paper breakdown → | 2003 | 795 |
| 2 | 2004 | 90 | |
| 3 | 2013 | 63 | |
| 4 | 2010 | 56 | |
| 5 | 2013 | 41 | |
| 6 | 1990 | 28 | |
| 7 | 2009 | 24 | |
| 8 | 2013 | 20 | |
| 9 | 2005 | 10 |
About Michael Pepoy
Michael Pepoy is a scholar working on Clinical Biochemistry, Cardiology and Cardiovascular Medicine, Immunology, Molecular Biology and Pharmacology, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Heart Failure Treatment and Management (1 paper), Congenital Heart Disease Studies (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Cynara cardunculus studies (1 paper), Protein Interaction Studies and Fluorescence Analysis (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Clinical Biochemistry (144 citations), Immunology (396 citations), Cardiology and Cardiovascular Medicine (259 citations), Biochemistry (40 citations) and Physiology (150 citations). Michael Pepoy has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Frederick Van Lente, Stanley L. Hazen, Ronnier J. Aviles, Marlene Goormastic, Eric J. Topol, Steven E. Nissen, Marie‐Luise Brennan, Marc S. Penn, Ellen McErlean and Vijay Nambi. Their work appears in journals such as Journal of the American Heart Association, Obstetrical & Gynecological Survey, Arteriosclerosis Thrombosis and Vascular Biology, Clinical Journal of the American Society of Nephrology and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.